September 14, 2022 | 59 mins

Come learn about how NSF I-Corps, Foundation Venture Capital Group(Link is external) (Link opens in new window), Foundation for Health Advancement(Link is external) (Link opens in new window), and New Jersey Health Foundation(Link is external) (Link opens in new window) can help you bring your research/technology closer to solving real-world problems, follow-on funding, and impacting lives! Whether you're far along in your commercialization journey or just starting out and wanting to learn more about innovation, all are welcome!

We will hear from the Foundation Venture Capital Group panel:

• Scott Alpizar, Director of Venture Commercialization will discuss the missions of Foundation Venture Capital Group, Foundation for Health Advacement, New Jersey Health Foundation, the programs that each has to offer, and what he looks for in terms of making investment decisions
• Mark Siracusa, Founder & President of NemaGen Discoveries, and Associate Professor in the Rutgers Center for Immunity & Inflammation, will introduce his startup company, and how his experience with I-Corps and NJHF & FVCG impacted the trajectory of his technology and his business